Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A – SIGNAL TRANSDUCTION AND TARGETED THERAPY

Martin-Broto, J; Martinez-Garcia, J; Moura, DS; Redondo, A; Gutierrez, A; Lopez-Pousa, A; Martinez-Trufero, J; Sevilla, I; Diaz-Beveridge, R; Solis-Hernandez, MP; Carnero, A; Perez, M; Marcilla, D; Garcia-Foncillas, J; Romero, P; Fernandez-Jara, J; Lopez-Lopez, D; Arribas, I; Hindi, N – 2023 – 10.1038/s41392-023-01661-8